{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T01:31:53Z","timestamp":1788485513853,"version":"build-2803163510"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,28]],"date-time":"2023-08-28T00:00:00Z","timestamp":1693180800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Translational Oncology"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.tranon.2023.101772","type":"journal-article","created":{"date-parts":[[2023,8,31]],"date-time":"2023-08-31T15:24:11Z","timestamp":1693495451000},"page":"101772","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["EGFR mutation testing from pleural effusions of non-small cell lung cancer patients at the institute for oncology and radiology of Serbia"],"prefix":"10.1016","volume":"37","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9485-6488","authenticated-orcid":false,"given":"Miodrag","family":"Vukovic","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3102-776X","authenticated-orcid":false,"given":"Miljana","family":"Tanic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0781-8433","authenticated-orcid":false,"given":"Ana","family":"Damjanovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0503-562X","authenticated-orcid":false,"given":"Marijana","family":"Pavlovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9179-2856","authenticated-orcid":false,"given":"Aleksandra","family":"Stanojevic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1986-1623","authenticated-orcid":false,"given":"Katarina","family":"Zivic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-0888-5719","authenticated-orcid":false,"given":"Valentina","family":"Karadzic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2990-0523","authenticated-orcid":false,"given":"Radmila","family":"Jankovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7604-9295","authenticated-orcid":false,"given":"Milena","family":"Cavic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tranon.2023.101772_bib0001","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S1470-2045(14)71173-8","article-title":"Afatinib versus cisplatin-based chemotherapy for EGFR mutation-positive lung adenocarcinoma (LUX-Lung 3 and LUX-Lung 6): analysis of overall survival data from two randomised, phase 3 trials","volume":"16","author":"Yang","year":"2015","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.tranon.2023.101772_bib0002","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1038\/nmat5019","article-title":"Cell-free DNA: treasure trove for cancer medicine","volume":"16","author":"Tani\u0107","year":"2017","journal-title":"Nat. Mater."},{"key":"10.1016\/j.tranon.2023.101772_bib0003","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1038\/nrclinonc.2013.110","article-title":"Liquid biopsy: monitoring cancer-genetics in the blood","volume":"10","author":"Crowley","year":"2013","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.tranon.2023.101772_bib0004","doi-asserted-by":"crossref","first-page":"2633","DOI":"10.1002\/1878-0261.12574","article-title":"Prospective detection of mutations in cerebrospinal fluid, pleural effusion, and ascites of advanced cancer patients to guide treatment decisions","volume":"13","author":"Villatoro","year":"2019","journal-title":"Mol. Oncol."},{"key":"10.1016\/j.tranon.2023.101772_bib0005","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1159\/000338169","article-title":"Pleural effusion in lung cancer: More questions than answers","volume":"83","author":"Froudarakis","year":"2012","journal-title":"Respiration"},{"key":"10.1016\/j.tranon.2023.101772_bib0006","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1111\/resp.12496","article-title":"Clinical features and survival of lung cancer patients with pleural effusions","volume":"20","author":"Porcel","year":"2015","journal-title":"Respirology"},{"issue":"Suppl 2","key":"10.1016\/j.tranon.2023.101772_bib0007","doi-asserted-by":"crossref","DOI":"10.1136\/thx.2010.136978","article-title":"Investigation of a unilateral pleural effusion in adults: british thoracic society pleural disease guideline 2010","volume":"65","author":"Hooper","year":"2010","journal-title":"Thorax"},{"key":"10.1016\/j.tranon.2023.101772_bib0008","first-page":"1021","article-title":"Pleural involvement in lung cancer","volume":"7","author":"Agalioti","year":"2015","journal-title":"J. Thorac. Dis."},{"key":"10.1016\/j.tranon.2023.101772_bib0009","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1097\/LBR.0000000000000789","article-title":"Cytologic investigations for the diagnosis of malignant pleural effusion in non-small cell lung cancer: state-of-the-art review for pulmonologists","volume":"28","author":"Shojaee","year":"2021","journal-title":"J. Bronchol. Interv. Pulmonol."},{"key":"10.1016\/j.tranon.2023.101772_bib0010","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1515\/pp-2016-0001","article-title":"Pre-analytical issues in effusion cytology","volume":"1","author":"Michael","year":"2016","journal-title":"Pleura Peritoneum"},{"key":"10.1016\/j.tranon.2023.101772_bib0011","doi-asserted-by":"crossref","DOI":"10.3389\/pore.2021.613071","article-title":"Cell-free DNA from pleural effusion samples: is it right for molecular testing in lung adenocarcinoma?","volume":"27","author":"Mok\u00e1nszki","year":"2021","journal-title":"Pathol. Oncol. Res."},{"key":"10.1016\/j.tranon.2023.101772_bib0012","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.7150\/ijms.52306","article-title":"Distinct profile of cell-free DNA in malignant pleural effusion of non-small cell lung cancer and its impact on clinical genetic testing","volume":"18","author":"Yu","year":"2021","journal-title":"Int. J. Med. Sci."},{"key":"10.1016\/j.tranon.2023.101772_bib0013","doi-asserted-by":"crossref","DOI":"10.1016\/j.mcp.2022.101793","article-title":"Malignant pleural effusions for cancer genotyping: A matter of trans-pleural traffic of cell-free tumor DNA","volume":"61","author":"M\u00e9hes","year":"2022","journal-title":"Mol. Cell. Probes"},{"key":"10.1016\/j.tranon.2023.101772_bib0014","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1515\/cclm-2016-0851","article-title":"Assessment of real-time PCR method for detection of EGFR mutation using both supernatant and cell pellet of malignant pleural effusion samples from non-small-cell lung cancer patients","volume":"55","author":"Shin","year":"2017","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.tranon.2023.101772_bib0015","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1111\/1759-7714.12979","article-title":"Prognostic impact of pleural effusion in EGFR-mutant non-small cell lung cancer patients without brain metastasis","volume":"10","author":"Yoshimura","year":"2019","journal-title":"Thorac. Cancer"},{"key":"10.1016\/j.tranon.2023.101772_bib0016","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.21037\/tlcr-20-882","article-title":"A multicenter real-world study of tumor-derived DNA from pleural effusion supernatant in genomic profiling of advanced lung cancer","volume":"9","author":"Jin","year":"2020","journal-title":"Transl. Lung Cancer Res."},{"key":"10.1016\/j.tranon.2023.101772_bib0017","doi-asserted-by":"crossref","first-page":"2631","DOI":"10.21037\/jtd.2018.04.125","article-title":"Next generation sequencing-based molecular profiling of lung adenocarcinoma using pleural effusion specimens","volume":"10","author":"Liu","year":"2018","journal-title":"J. Thorac. Dis."},{"key":"10.1016\/j.tranon.2023.101772_bib0018","doi-asserted-by":"crossref","first-page":"115","DOI":"10.2147\/CMAR.S148134","article-title":"A comparison of QuantStudioTM 3D digital PCR and ARMS-PCR for measuring plasma EGFR T790M mutations of NSCLC patients","volume":"10","author":"Feng","year":"2018","journal-title":"Cancer Manag. Res."},{"key":"10.1016\/j.tranon.2023.101772_bib0019","doi-asserted-by":"crossref","DOI":"10.3390\/diagnostics10121062","article-title":"Detection of EGFR mutations in plasma cell-free tumor dna of tki-treated advanced-nsclc patients by three methodologies: Scorpion-arms, pnaclamp, and digital pcr","volume":"10","author":"Siggillino","year":"2020","journal-title":"Diagnostics"},{"key":"10.1016\/j.tranon.2023.101772_bib0020","first-page":"2635","article-title":"EGFR mutation testing from liquid biopsy of non-small cell lung cancer at the Institute for oncology and radiology of Serbia","volume":"25","author":"Cavic","year":"2020","journal-title":"J. BUON"},{"key":"10.1016\/j.tranon.2023.101772_bib0021","first-page":"1287","article-title":"Pharmacogenetics in cancer therapy - 8 years of experience at the institute for oncology and radiology of Serbia","volume":"21","author":"Cavic","year":"2016","journal-title":"J. BUON"},{"key":"10.1016\/j.tranon.2023.101772_bib0022","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/j.jtho.2022.04.010","article-title":"Lung cancer in Serbia","volume":"17","author":"Cavic","year":"2022","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.tranon.2023.101772_bib0023","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1080\/14737159.2021.1860760","article-title":"Exploring the real-world effect of the SARS-CoV-2 pandemic on the molecular diagnostics for cancer patients and high-risk individuals","volume":"21","author":"Cavic","year":"2021","journal-title":"Expert Rev. Mol. Diagn."},{"key":"10.1016\/j.tranon.2023.101772_bib0024","first-page":"1024","article-title":"The influence of methylenetetrahydrofolate reductase and thymidylate synthetase gene polymorphisms on lung adenocarcinoma occurrence","volume":"19","author":"Cavic","year":"2014","journal-title":"J. BUON"},{"key":"10.1016\/j.tranon.2023.101772_bib0025","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1080\/14737140.2021.1893694","article-title":"Hematological parameters in EGFR-mutated advanced NSCLC patients treated with TKIs: predicting survival and toxicity","volume":"21","author":"Jokic","year":"2021","journal-title":"Expert Rev. Anticancer Ther."},{"key":"10.1016\/j.tranon.2023.101772_bib0026","doi-asserted-by":"crossref","DOI":"10.1177\/15593258221117354","article-title":"Evaluation of clinical and genetic determinants of treatment outcome in EGFR mutation positive advanced lung adenocarcinoma","volume":"20","author":"Jokic","year":"2022","journal-title":"Dose Response"},{"key":"10.1016\/j.tranon.2023.101772_bib0027","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1136\/jclinpath-2018-205553","article-title":"TP53 and DNA-repair gene polymorphisms genotyping as a low-cost lung adenocarcinoma screening tool","volume":"72","author":"Cavic","year":"2019","journal-title":"J. Clin. Pathol."},{"key":"10.1016\/j.tranon.2023.101772_bib0028","doi-asserted-by":"crossref","DOI":"10.1177\/15593258221111666","article-title":"Low-cost genetic and clinical predictors of response and toxicity of platinum-based chemotherapy in advanced non-small cell lung cancer","volume":"20","author":"Spasic","year":"2022","journal-title":"Dose Response"},{"key":"10.1016\/j.tranon.2023.101772_bib0029","first-page":"256","article-title":"Tumor characteristics, expressions of ERCC1, Bax, p53, IGF1R, Bcl2, Bcl2\/Bax and prognostic factors for overall survival in patients with lung carcinoid","volume":"24","author":"Velinovic","year":"2019","journal-title":"J. BUON"},{"key":"10.1016\/j.tranon.2023.101772_bib0030","first-page":"11","article-title":"LungCARD - Report on worldwide research and clinical practices related to lung cancer","volume":"24","author":"Jankovic","year":"2019","journal-title":"J. BUON"},{"key":"10.1016\/j.tranon.2023.101772_bib0031","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.annonc.2022.02.003","article-title":"ESMO expert consensus statements on the management of <em>EGFR<\/em>mutant non-small-cell lung cancer","volume":"33","author":"Passaro","year":"2022","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.tranon.2023.101772_bib0032","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.jmoldx.2013.03.001","article-title":"Molecular testing guideline for selection of lung cancer patients for EGFR and ALK tyrosine kinase inhibitors guideline from the college of american pathologists, international association for the study of lung cancer, and association for molecular path","volume":"15","author":"Lindeman","year":"2013","journal-title":"J. Mol. Diagn."},{"key":"10.1016\/j.tranon.2023.101772_bib0033","article-title":"Sensitive cell-free tumor DNA analysis in supernatant pleural effusions supports therapy selection and disease monitoring of lung cancer patients","volume":"29","author":"de Kock","year":"2021","journal-title":"Cancer Treat. Res. Commun."},{"key":"10.1016\/j.tranon.2023.101772_bib0034","doi-asserted-by":"crossref","first-page":"2218","DOI":"10.1111\/1759-7714.13201","article-title":"Detection of EGFR gene mutation status from pleural effusions and other body fluid specimens in patients with lung adenocarcinoma","volume":"10","author":"Zhang","year":"2019","journal-title":"Thorac. Cancer"},{"key":"10.1016\/j.tranon.2023.101772_bib0035","doi-asserted-by":"crossref","first-page":"3347","DOI":"10.1007\/s12325-022-02189-z","article-title":"Real-world patient characteristics, treatment patterns, and mutation testing patterns among US patients with advanced non-small cell lung cancer harboring EGFR mutations","volume":"39","author":"He","year":"2022","journal-title":"Adv. Ther."},{"key":"10.1016\/j.tranon.2023.101772_bib0036","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.lungcan.2017.08.021","article-title":"EGFR mutation prevalence in Asia-Pacific and Russian patients with advanced NSCLC of adenocarcinoma and non-adenocarcinoma histology: The IGNITE study","volume":"113","author":"Han","year":"2017","journal-title":"Lung Cancer"},{"key":"10.1016\/j.tranon.2023.101772_bib0037","doi-asserted-by":"crossref","first-page":"e70","DOI":"10.1097\/JTO.0000000000000251","article-title":"<em>EGFR<\/em>mutations in Asian patients with advanced lung adenocarcinoma","volume":"9","author":"Liam","year":"2014","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.tranon.2023.101772_bib0038","unstructured":"World Health Organization Regional Office for Europe (2019) Health impact of ambient air pollution in Serbia A CALL TO ACTION. Available at: https:\/\/serbia.un.org\/sites\/default\/files\/2019-10\/Health-impact-pollution-Serbia_0.pdf. Accessed on August 30, 2023."},{"key":"10.1016\/j.tranon.2023.101772_bib0039","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.jtho.2021.07.031","article-title":"Screening for lung cancer in individuals who never smoked: an international association for the study of lung cancer early detection and screening committee report","volume":"17","author":"Kerpel-Fronius","year":"2022","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.tranon.2023.101772_bib0040","doi-asserted-by":"crossref","DOI":"10.3390\/jpm12111845","article-title":"Pitfalls and rewards of setting up a liquid biopsy approach for the detection of driver mutations in circulating tumor DNAs: our institutional experience","volume":"12","author":"Chen","year":"2022","journal-title":"J. Pers. Med."},{"key":"10.1016\/j.tranon.2023.101772_bib0041","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2022.101589","article-title":"Up-front mutation detection in circulating tumor DNA by droplet digital PCR has added diagnostic value in lung cancer","volume":"27","author":"Visser","year":"2023","journal-title":"Transl. Oncol."},{"key":"10.1016\/j.tranon.2023.101772_bib0042","first-page":"1","article-title":"Monitoring of T790M in plasma ctDNA of advanced EGFR-mutant NSCLC patients on first- or second-generation tyrosine kinase inhibitors","volume":"23","author":"Huang","year":"2023","journal-title":"BMC Cancer"},{"key":"10.1016\/j.tranon.2023.101772_bib0043","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1513\/AnnalsATS.202107-810RL","article-title":"Cell-free DNA concentration and pattern fragmentation in pleural fluid and plasma to detect malignant effusions","volume":"19","author":"Porcel","year":"2022","journal-title":"Ann. Am. Thorac. Soc."},{"key":"10.1016\/j.tranon.2023.101772_bib0044","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.lungcan.2022.10.013","article-title":"EGFR testing in paraffin-embedded cell block cytology material is reliable with increased detection for effusion fluid","volume":"174","author":"Man Ng","year":"2022","journal-title":"Lung Cancer"},{"key":"10.1016\/j.tranon.2023.101772_bib0045","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.810124","article-title":"Cytology\u2013based specimen triage for epidermal growth factor receptor mutation testing of malignant pleural effusions in non\u2013small cell lung cancer","volume":"12","author":"Chiang","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.tranon.2023.101772_bib0046","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1056\/NEJMoa1612674","article-title":"Osimertinib or platinum\u2013pemetrexed in EGFR T790M\u2013positive lung cancer","volume":"376","author":"Mok","year":"2017","journal-title":"N. Engl. J. Med."}],"container-title":["Translational Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936523323001584?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936523323001584?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T17:26:56Z","timestamp":1761845216000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1936523323001584"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":46,"alternative-id":["S1936523323001584"],"URL":"https:\/\/doi.org\/10.1016\/j.tranon.2023.101772","relation":{},"ISSN":["1936-5233"],"issn-type":[{"value":"1936-5233","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"EGFR mutation testing from pleural effusions of non-small cell lung cancer patients at the institute for oncology and radiology of Serbia","name":"articletitle","label":"Article Title"},{"value":"Translational Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tranon.2023.101772","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"101772"}}